Tower Research Capital LLC (Trc) Galapagos Nv Transaction History
Tower Research Capital LLC (Trc)
- $3.68 Billion
- Q3 2024
A detailed history of Tower Research Capital LLC (Trc) transactions in Galapagos Nv stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 357 shares of GLPG stock, worth $8,507. This represents 0.0% of its overall portfolio holdings.
Number of Shares
357
Previous 5,479
93.48%
Holding current value
$8,507
Previous $135,000
92.59%
% of portfolio
0.0%
Previous 0.0%
Shares
29 transactions
Others Institutions Holding GLPG
# of Institutions
84Shares Held
12.3MCall Options Held
69.1KPut Options Held
42.7K-
Bvf Inc San Francisco, CA1.57MShares$37.4 Million1.44% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY1.41MShares$33.6 Million0.76% of portfolio
-
Prosight Management, LP Dallas, TX1.03MShares$24.5 Million7.95% of portfolio
-
Logos Global Management LP San Francisco, CA800KShares$19.1 Million3.05% of portfolio
-
Primecap Management CO Pasadena, CA720KShares$17.2 Million0.02% of portfolio
About GALAPAGOS NV
- Ticker GLPG
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 65,835,500
- Market Cap $1.57B
- Description
- Galapagos NV, an integrated biopharmaceutical company, engages in the discovery, development, and commercialization of various medicines for high unmet medical need. Its pipeline products include filgotinib, a JAK1 inhibitor that is in various phases of clinical trials for the treatment of rheumatoid arthritis, Crohn's disease, ulcerative coliti...